The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clear and non-clear cell renal cell carcinomas and the ability to engage in oxidative phosphorylation.
 
Ziad Bakouny
Honoraria - UpToDate
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
(OPTIONAL) Uncompensated Relationships - ASCO IMG Community of Practice; Dana-Farber Cancer Institute; IMG Oncologists (NGO)
 
Sonia Boscenco
No Relationships to Disclose
 
Ruobing Cui
No Relationships to Disclose
 
Keunwoo Ryu
No Relationships to Disclose
 
Ritesh Kotecha
Consulting or Advisory Role - Eisai; Eisai; Guidepoint Inc; Guidepoint Inc
Research Funding - Allogene Therapeutics (Inst); ArsenalBio (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst); Xencor (Inst)
 
Marie Carlo
Honoraria - OncLive/MJH Life Sciences; OncLive/MJH Life Sciences
Other Relationship - Kidney Cancer Association; Prostate Cancer Foundation; Robert Wood Johnson Foundation
 
Martin Voss
Consulting or Advisory Role - Affimed Therapeutics; AstraZeneca; AVEO; Eisai; Exelixis; Merck; Oncorena
Research Funding - Exelixis; Pfizer; Regeneron
(OPTIONAL) Uncompensated Relationships - Aravive; AstraZeneca; BMS; Genentech/Roche; NiKang Therapeutics
 
A. Hakimi
Research Funding - Merck
 
Robert Motzer
Consulting or Advisory Role - Aveo; EMD Serono; Exelixis; Incyte; Merck; Takeda
Research Funding - Aveo (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Payam Gammage
Stock and Other Ownership Interests - Pretzel Therapeutics Inc
Consulting or Advisory Role - Pretzel Therapeutics Inc
Patents, Royalties, Other Intellectual Property - Pretzel Therapeutics Inc
 
Eduard Reznik
No Relationships to Disclose
 
Craig Thompson
Leadership - Charles River Laboratories; Regeneron
Stock and Other Ownership Interests - Charles River Laboratories; Regeneron
Patents, Royalties, Other Intellectual Property - Elsevier